| Literature DB >> 26728997 |
Takayuki Ikeda1, Yasuo Yoshitomi1, Hidehito Saito1, Takeo Shimasaki2, Hideki Yamaya3, Takashi Kobata4, Yasuhito Ishigaki2, Naohisa Tomosugi2, Yoshino Yoshitake1, Hideto Yonekura5.
Abstract
Soluble fms-like tyrosine kinase-1 (sFlt-1) functions as a potent inhibitor of angiogenesis by trapping vascular endothelial growth factor (VEGF). However, the precise regulatory mechanism of sFlt-1 production is unknown. Here, we report that vascular sFlt-1 production is regulated by heterogeneous nuclear ribonucleoprotein D (hnRNP D) and arginine methylation. We showed that hnRNP D bound to Flt-1 pre-mRNA and that hnRNP D overexpression decreased sFlt-1 mRNA in human microvascular endothelial cells (HMVECs). In contrast, the reduction of hnRNP D levels induced an increase in sFlt-1 production. Overexpression of an hnRNP D mutant in which the arginine residue of the known arginine methylation motif (arginine-glycine-glycine; RGG) was replaced with alanine did not reduce the level of soluble-form RNA produced from the Flt-1 minigene. Moreover, we demonstrated that overexpression of arginine methyltransferase decreased the soluble-form RNA level, whereas overexpression of arginine demethylase and addition of methyltransferase inhibitors increased sFlt-1 mRNA levels. These findings indicate that hnRNP D and arginine methylation play important roles in the regulation of Flt-1 mRNA alternative polyadenylation.Entities:
Keywords: Alternative polyadenylation; Arginine methylation; VEGF; hnRNP D; sFlt-1
Mesh:
Substances:
Year: 2016 PMID: 26728997 DOI: 10.1007/s11010-015-2649-y
Source DB: PubMed Journal: Mol Cell Biochem ISSN: 0300-8177 Impact factor: 3.396